English
简体中文
Total: £ 56.28
Published Date: 2026-01-22 | Pages: 112 | Tables: 116 | Medical Care
The global Commercial Drug Manufacturing Service market was valued at US$ 1929 million in 2025 and is anticipated to reach US$ 2809 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Commercial drug manufacturing service refers to a series of manufacturing services provided to pharmaceutical companies or research institutions, covering the entire process from drug raw material processing to final product packaging. These services encompass various aspects of drug production, including raw material procurement and inspection, drug formula design and optimization, formulation production and quality control, as well as product packaging and labeling. Commercial Drug Manufacturing Services typically adhere to strict production standards and quality control systems to ensure that the produced drugs meet relevant regulatory requirements and quality standards. Furthermore, these services offer flexible production capabilities and the ability to quickly respond to market changes, helping pharmaceutical companies rapidly launch new drugs or improve existing products to meet market demands. Through Commercial Drug Manufacturing Services, pharmaceutical companies can reduce costs, improve efficiency, and focus on core businesses such as drug research and development and market expansion.
The North American market for Commercial Drug Manufacturing Service is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Commercial Drug Manufacturing Service is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Commercial Drug Manufacturing Service in Tablet is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Commercial Drug Manufacturing Service include Pyramid Labs, Almac Group, Piramal Pharma, Altasciences, UPM Pharmaceuticals, Aphena Pharma Solutions, Quotient Sciences, Thermo Fisher Scientific, PCI, Torbay Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Commercial Drug Manufacturing Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Commercial Drug Manufacturing Service. The Commercial Drug Manufacturing Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Commercial Drug Manufacturing Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Commercial Drug Manufacturing Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pyramid Labs
Almac Group
Piramal Pharma
Altasciences
UPM Pharmaceuticals
Aphena Pharma Solutions
Quotient Sciences
Thermo Fisher Scientific
PCI
Torbay Pharma
Experic
Carbogen-Amcis
AbbVie
Alcami
Lonza
Segment by Type
Small Batch Manufacturing Services
Large-Scale Manufacturing Services
Segment by Application
Tablet
Capsule
Inhalation Drug
Biologics
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Commercial Drug Manufacturing Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Commercial Drug Manufacturing Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Small Batch Manufacturing Services
1.2.3 Large-Scale Manufacturing Services
1.3 Market by Application
1.3.1 Global Commercial Drug Manufacturing Service Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Inhalation Drug
1.3.5 Biologics
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Commercial Drug Manufacturing Service Market Perspective (2021–2032)
2.2 Global Commercial Drug Manufacturing Service Growth Trends by Region
2.2.1 Global Commercial Drug Manufacturing Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Commercial Drug Manufacturing Service Historic Market Size by Region (2021–2026)
2.2.3 Commercial Drug Manufacturing Service Forecasted Market Size by Region (2027–2032)
2.3 Commercial Drug Manufacturing Service Market Dynamics
2.3.1 Commercial Drug Manufacturing Service Industry Trends
2.3.2 Commercial Drug Manufacturing Service Market Drivers
2.3.3 Commercial Drug Manufacturing Service Market Challenges
2.3.4 Commercial Drug Manufacturing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Commercial Drug Manufacturing Service Players by Revenue
3.1.1 Global Top Commercial Drug Manufacturing Service Players by Revenue (2021–2026)
3.1.2 Global Commercial Drug Manufacturing Service Revenue Market Share by Players (2021–2026)
3.2 Global Top Commercial Drug Manufacturing Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Commercial Drug Manufacturing Service Revenue
3.4 Global Commercial Drug Manufacturing Service Market Concentration Ratio
3.4.1 Global Commercial Drug Manufacturing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Commercial Drug Manufacturing Service Revenue in 2025
3.5 Global Key Players of Commercial Drug Manufacturing Service Head Offices and Areas Served
3.6 Global Key Players of Commercial Drug Manufacturing Service, Products and Applications
3.7 Global Key Players of Commercial Drug Manufacturing Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Commercial Drug Manufacturing Service Breakdown Data by Type
4.1 Global Commercial Drug Manufacturing Service Historic Market Size by Type (2021–2026)
4.2 Global Commercial Drug Manufacturing Service Forecasted Market Size by Type (2027–2032)
5 Commercial Drug Manufacturing Service Breakdown Data by Application
5.1 Global Commercial Drug Manufacturing Service Historic Market Size by Application (2021–2026)
5.2 Global Commercial Drug Manufacturing Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Commercial Drug Manufacturing Service Market Size (2021–2032)
6.2 North America Commercial Drug Manufacturing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Commercial Drug Manufacturing Service Market Size by Country (2021–2026)
6.4 North America Commercial Drug Manufacturing Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Commercial Drug Manufacturing Service Market Size (2021–2032)
7.2 Europe Commercial Drug Manufacturing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Commercial Drug Manufacturing Service Market Size by Country (2021–2026)
7.4 Europe Commercial Drug Manufacturing Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Commercial Drug Manufacturing Service Market Size (2021–2032)
8.2 Asia-Pacific Commercial Drug Manufacturing Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Commercial Drug Manufacturing Service Market Size by Region (2021–2026)
8.4 Asia-Pacific Commercial Drug Manufacturing Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Commercial Drug Manufacturing Service Market Size (2021–2032)
9.2 Latin America Commercial Drug Manufacturing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Commercial Drug Manufacturing Service Market Size by Country (2021–2026)
9.4 Latin America Commercial Drug Manufacturing Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Commercial Drug Manufacturing Service Market Size (2021–2032)
10.2 Middle East & Africa Commercial Drug Manufacturing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Commercial Drug Manufacturing Service Market Size by Country (2021–2026)
10.4 Middle East & Africa Commercial Drug Manufacturing Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pyramid Labs
11.1.1 Pyramid Labs Company Details
11.1.2 Pyramid Labs Business Overview
11.1.3 Pyramid Labs Commercial Drug Manufacturing Service Introduction
11.1.4 Pyramid Labs Revenue in Commercial Drug Manufacturing Service Business (2021–2026)
11.1.5 Pyramid Labs Recent Development
11.2 Almac Group
11.2.1 Almac Group Company Details
11.2.2 Almac Group Business Overview
11.2.3 Almac Group Commercial Drug Manufacturing Service Introduction
11.2.4 Almac Group Revenue in Commercial Drug Manufacturing Service Business (2021–2026)
11.2.5 Almac Group Recent Development
11.3 Piramal Pharma
11.3.1 Piramal Pharma Company Details
11.3.2 Piramal Pharma Business Overview
11.3.3 Piramal Pharma Commercial Drug Manufacturing Service Introduction
11.3.4 Piramal Pharma Revenue in Commercial Drug Manufacturing Service Business (2021–2026)
11.3.5 Piramal Pharma Recent Development
11.4 Altasciences
11.4.1 Altasciences Company Details
11.4.2 Altasciences Business Overview
11.4.3 Altasciences Commercial Drug Manufacturing Service Introduction
11.4.4 Altasciences Revenue in Commercial Drug Manufacturing Service Business (2021–2026)
11.4.5 Altasciences Recent Development
11.5 UPM Pharmaceuticals
11.5.1 UPM Pharmaceuticals Company Details
11.5.2 UPM Pharmaceuticals Business Overview
11.5.3 UPM Pharmaceuticals Commercial Drug Manufacturing Service Introduction
11.5.4 UPM Pharmaceuticals Revenue in Commercial Drug Manufacturing Service Business (2021–2026)
11.5.5 UPM Pharmaceuticals Recent Development
11.6 Aphena Pharma Solutions
11.6.1 Aphena Pharma Solutions Company Details
11.6.2 Aphena Pharma Solutions Business Overview
11.6.3 Aphena Pharma Solutions Commercial Drug Manufacturing Service Introduction
11.6.4 Aphena Pharma Solutions Revenue in Commercial Drug Manufacturing Service Business (2021–2026)
11.6.5 Aphena Pharma Solutions Recent Development
11.7 Quotient Sciences
11.7.1 Quotient Sciences Company Details
11.7.2 Quotient Sciences Business Overview
11.7.3 Quotient Sciences Commercial Drug Manufacturing Service Introduction
11.7.4 Quotient Sciences Revenue in Commercial Drug Manufacturing Service Business (2021–2026)
11.7.5 Quotient Sciences Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Commercial Drug Manufacturing Service Introduction
11.8.4 Thermo Fisher Scientific Revenue in Commercial Drug Manufacturing Service Business (2021–2026)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 PCI
11.9.1 PCI Company Details
11.9.2 PCI Business Overview
11.9.3 PCI Commercial Drug Manufacturing Service Introduction
11.9.4 PCI Revenue in Commercial Drug Manufacturing Service Business (2021–2026)
11.9.5 PCI Recent Development
11.10 Torbay Pharma
11.10.1 Torbay Pharma Company Details
11.10.2 Torbay Pharma Business Overview
11.10.3 Torbay Pharma Commercial Drug Manufacturing Service Introduction
11.10.4 Torbay Pharma Revenue in Commercial Drug Manufacturing Service Business (2021–2026)
11.10.5 Torbay Pharma Recent Development
11.11 Experic
11.11.1 Experic Company Details
11.11.2 Experic Business Overview
11.11.3 Experic Commercial Drug Manufacturing Service Introduction
11.11.4 Experic Revenue in Commercial Drug Manufacturing Service Business (2021–2026)
11.11.5 Experic Recent Development
11.12 Carbogen-Amcis
11.12.1 Carbogen-Amcis Company Details
11.12.2 Carbogen-Amcis Business Overview
11.12.3 Carbogen-Amcis Commercial Drug Manufacturing Service Introduction
11.12.4 Carbogen-Amcis Revenue in Commercial Drug Manufacturing Service Business (2021–2026)
11.12.5 Carbogen-Amcis Recent Development
11.13 AbbVie
11.13.1 AbbVie Company Details
11.13.2 AbbVie Business Overview
11.13.3 AbbVie Commercial Drug Manufacturing Service Introduction
11.13.4 AbbVie Revenue in Commercial Drug Manufacturing Service Business (2021–2026)
11.13.5 AbbVie Recent Development
11.14 Alcami
11.14.1 Alcami Company Details
11.14.2 Alcami Business Overview
11.14.3 Alcami Commercial Drug Manufacturing Service Introduction
11.14.4 Alcami Revenue in Commercial Drug Manufacturing Service Business (2021–2026)
11.14.5 Alcami Recent Development
11.15 Lonza
11.15.1 Lonza Company Details
11.15.2 Lonza Business Overview
11.15.3 Lonza Commercial Drug Manufacturing Service Introduction
11.15.4 Lonza Revenue in Commercial Drug Manufacturing Service Business (2021–2026)
11.15.5 Lonza Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Commercial Drug Manufacturing Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Small Batch Manufacturing Services
Table 3. Key Players of Large-Scale Manufacturing Services
Table 4. Global Commercial Drug Manufacturing Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Commercial Drug Manufacturing Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Commercial Drug Manufacturing Service Market Size by Region (US$ Million), 2021–2026
Table 7. Global Commercial Drug Manufacturing Service Market Share by Region (2021–2026)
Table 8. Global Commercial Drug Manufacturing Service Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Commercial Drug Manufacturing Service Market Share by Region (2027–2032)
Table 10. Commercial Drug Manufacturing Service Market Trends
Table 11. Commercial Drug Manufacturing Service Market Drivers
Table 12. Commercial Drug Manufacturing Service Market Challenges
Table 13. Commercial Drug Manufacturing Service Market Restraints
Table 14. Global Commercial Drug Manufacturing Service Revenue by Players (US$ Million), 2021–2026
Table 15. Global Commercial Drug Manufacturing Service Market Share by Players (2021–2026)
Table 16. Global Top Commercial Drug Manufacturing Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Commercial Drug Manufacturing Service Revenue, 2025
Table 17. Ranking of Global Top Commercial Drug Manufacturing Service Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Commercial Drug Manufacturing Service Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Commercial Drug Manufacturing Service, Headquarters and Area Served
Table 20. Global Key Players of Commercial Drug Manufacturing Service, Products and Applications
Table 21. Global Key Players of Commercial Drug Manufacturing Service, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Commercial Drug Manufacturing Service Market Size by Type (US$ Million), 2021–2026
Table 24. Global Commercial Drug Manufacturing Service Revenue Market Share by Type (2021–2026)
Table 25. Global Commercial Drug Manufacturing Service Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Commercial Drug Manufacturing Service Revenue Market Share by Type (2027–2032)
Table 27. Global Commercial Drug Manufacturing Service Market Size by Application (US$ Million), 2021–2026
Table 28. Global Commercial Drug Manufacturing Service Revenue Market Share by Application (2021–2026)
Table 29. Global Commercial Drug Manufacturing Service Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Commercial Drug Manufacturing Service Revenue Market Share by Application (2027–2032)
Table 31. North America Commercial Drug Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Commercial Drug Manufacturing Service Market Size by Country (US$ Million), 2021–2026
Table 33. North America Commercial Drug Manufacturing Service Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Commercial Drug Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Commercial Drug Manufacturing Service Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Commercial Drug Manufacturing Service Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Commercial Drug Manufacturing Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Commercial Drug Manufacturing Service Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Commercial Drug Manufacturing Service Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Commercial Drug Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Commercial Drug Manufacturing Service Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Commercial Drug Manufacturing Service Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Commercial Drug Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Commercial Drug Manufacturing Service Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Commercial Drug Manufacturing Service Market Size by Country (US$ Million), 2027–2032
Table 46. Pyramid Labs Company Details
Table 47. Pyramid Labs Business Overview
Table 48. Pyramid Labs Commercial Drug Manufacturing Service Product
Table 49. Pyramid Labs Revenue in Commercial Drug Manufacturing Service Business (US$ Million), 2021–2026
Table 50. Pyramid Labs Recent Development
Table 51. Almac Group Company Details
Table 52. Almac Group Business Overview
Table 53. Almac Group Commercial Drug Manufacturing Service Product
Table 54. Almac Group Revenue in Commercial Drug Manufacturing Service Business (US$ Million), 2021–2026
Table 55. Almac Group Recent Development
Table 56. Piramal Pharma Company Details
Table 57. Piramal Pharma Business Overview
Table 58. Piramal Pharma Commercial Drug Manufacturing Service Product
Table 59. Piramal Pharma Revenue in Commercial Drug Manufacturing Service Business (US$ Million), 2021–2026
Table 60. Piramal Pharma Recent Development
Table 61. Altasciences Company Details
Table 62. Altasciences Business Overview
Table 63. Altasciences Commercial Drug Manufacturing Service Product
Table 64. Altasciences Revenue in Commercial Drug Manufacturing Service Business (US$ Million), 2021–2026
Table 65. Altasciences Recent Development
Table 66. UPM Pharmaceuticals Company Details
Table 67. UPM Pharmaceuticals Business Overview
Table 68. UPM Pharmaceuticals Commercial Drug Manufacturing Service Product
Table 69. UPM Pharmaceuticals Revenue in Commercial Drug Manufacturing Service Business (US$ Million), 2021–2026
Table 70. UPM Pharmaceuticals Recent Development
Table 71. Aphena Pharma Solutions Company Details
Table 72. Aphena Pharma Solutions Business Overview
Table 73. Aphena Pharma Solutions Commercial Drug Manufacturing Service Product
Table 74. Aphena Pharma Solutions Revenue in Commercial Drug Manufacturing Service Business (US$ Million), 2021–2026
Table 75. Aphena Pharma Solutions Recent Development
Table 76. Quotient Sciences Company Details
Table 77. Quotient Sciences Business Overview
Table 78. Quotient Sciences Commercial Drug Manufacturing Service Product
Table 79. Quotient Sciences Revenue in Commercial Drug Manufacturing Service Business (US$ Million), 2021–2026
Table 80. Quotient Sciences Recent Development
Table 81. Thermo Fisher Scientific Company Details
Table 82. Thermo Fisher Scientific Business Overview
Table 83. Thermo Fisher Scientific Commercial Drug Manufacturing Service Product
Table 84. Thermo Fisher Scientific Revenue in Commercial Drug Manufacturing Service Business (US$ Million), 2021–2026
Table 85. Thermo Fisher Scientific Recent Development
Table 86. PCI Company Details
Table 87. PCI Business Overview
Table 88. PCI Commercial Drug Manufacturing Service Product
Table 89. PCI Revenue in Commercial Drug Manufacturing Service Business (US$ Million), 2021–2026
Table 90. PCI Recent Development
Table 91. Torbay Pharma Company Details
Table 92. Torbay Pharma Business Overview
Table 93. Torbay Pharma Commercial Drug Manufacturing Service Product
Table 94. Torbay Pharma Revenue in Commercial Drug Manufacturing Service Business (US$ Million), 2021–2026
Table 95. Torbay Pharma Recent Development
Table 96. Experic Company Details
Table 97. Experic Business Overview
Table 98. Experic Commercial Drug Manufacturing Service Product
Table 99. Experic Revenue in Commercial Drug Manufacturing Service Business (US$ Million), 2021–2026
Table 100. Experic Recent Development
Table 101. Carbogen-Amcis Company Details
Table 102. Carbogen-Amcis Business Overview
Table 103. Carbogen-Amcis Commercial Drug Manufacturing Service Product
Table 104. Carbogen-Amcis Revenue in Commercial Drug Manufacturing Service Business (US$ Million), 2021–2026
Table 105. Carbogen-Amcis Recent Development
Table 106. AbbVie Company Details
Table 107. AbbVie Business Overview
Table 108. AbbVie Commercial Drug Manufacturing Service Product
Table 109. AbbVie Revenue in Commercial Drug Manufacturing Service Business (US$ Million), 2021–2026
Table 110. AbbVie Recent Development
Table 111. Alcami Company Details
Table 112. Alcami Business Overview
Table 113. Alcami Commercial Drug Manufacturing Service Product
Table 114. Alcami Revenue in Commercial Drug Manufacturing Service Business (US$ Million), 2021–2026
Table 115. Alcami Recent Development
Table 116. Lonza Company Details
Table 117. Lonza Business Overview
Table 118. Lonza Commercial Drug Manufacturing Service Product
Table 119. Lonza Revenue in Commercial Drug Manufacturing Service Business (US$ Million), 2021–2026
Table 120. Lonza Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Commercial Drug Manufacturing Service Picture
Figure 2. Global Commercial Drug Manufacturing Service Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Commercial Drug Manufacturing Service Market Share by Type: 2025 vs 2032
Figure 4. Small Batch Manufacturing Services Features
Figure 5. Large-Scale Manufacturing Services Features
Figure 6. Global Commercial Drug Manufacturing Service Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Commercial Drug Manufacturing Service Market Share by Application: 2025 vs 2032
Figure 8. Tablet Case Studies
Figure 9. Capsule Case Studies
Figure 10. Inhalation Drug Case Studies
Figure 11. Biologics Case Studies
Figure 12. Others Case Studies
Figure 13. Commercial Drug Manufacturing Service Report Years Considered
Figure 14. Global Commercial Drug Manufacturing Service Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Commercial Drug Manufacturing Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Commercial Drug Manufacturing Service Market Share by Region: 2025 vs 2032
Figure 17. Global Commercial Drug Manufacturing Service Market Share by Players in 2025
Figure 18. Global Commercial Drug Manufacturing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Commercial Drug Manufacturing Service Revenue in 2025
Figure 20. North America Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Commercial Drug Manufacturing Service Market Share by Country (2021–2032)
Figure 22. United States Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Commercial Drug Manufacturing Service Market Share by Country (2021–2032)
Figure 26. Germany Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Commercial Drug Manufacturing Service Market Share by Region (2021–2032)
Figure 34. China Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Commercial Drug Manufacturing Service Market Share by Country (2021–2032)
Figure 42. Mexico Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Commercial Drug Manufacturing Service Market Share by Country (2021–2032)
Figure 46. Israel Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Commercial Drug Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Pyramid Labs Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2021–2026)
Figure 50. Almac Group Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2021–2026)
Figure 51. Piramal Pharma Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2021–2026)
Figure 52. Altasciences Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2021–2026)
Figure 53. UPM Pharmaceuticals Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2021–2026)
Figure 54. Aphena Pharma Solutions Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2021–2026)
Figure 55. Quotient Sciences Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2021–2026)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2021–2026)
Figure 57. PCI Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2021–2026)
Figure 58. Torbay Pharma Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2021–2026)
Figure 59. Experic Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2021–2026)
Figure 60. Carbogen-Amcis Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2021–2026)
Figure 61. AbbVie Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2021–2026)
Figure 62. Alcami Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2021–2026)
Figure 63. Lonza Revenue Growth Rate in Commercial Drug Manufacturing Service Business (2021–2026)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
